Influence of carbenoxolone on the anticonvulsant efficacy of conventional antiepileptic drugs against audiogenic seizures in DBA/2 mice

European Journal of Pharmacology

Volumn 484, Issue 1, 2004, Pages 49-56

  Gareri, Pietro ^a   Condorelli, Daniele ^b   Belluardo, Natale ^c   Gratteri, Santo ^a   Ferreri, Guido ^a   Donato Di Paola, Eugenio ^a   De Sarro, Angela ^d   De Sarro, Giovambattista ^a  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^b UNIVERSITY OF CATANIA   (Italy)

^c UNIVERSITY OF PALERMO   (Italy)

^d UNIVERSITY OF MESSINA   (Italy)

Author keywords

Anticonvulsant potency; Antiepileptic drug; Audiogenic seizure; Carbamazepine; Carbenoxolone; DBA 2; Epilepsy; Felbamate; Gap junction; Mouse; Phenytoin; Valproate

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CARBENOXOLONE; DIAZEPAM; FELBAMATE; GABAPENTIN; GLYCYRRHIZIC ACID; LAMOTRIGINE; PHENOBARBITAL; PHENYTOIN; VALPROIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; AUDIOGENIC SEIZURE; AUDITORY STIMULATION; BODY TEMPERATURE; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG EFFICACY; DRUG MEGADOSE; DRUG POTENCY; DRUG POTENTIATION; MOTOR ACTIVITY; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0346687567     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2003.10.047     Document Type: Article

References (42)

1. Belluardo N., Trovato-Salinaro A., Mudò G., Hurd Y.L., Condorelli D.F. Structure, chromosomal localization, and brain expression of human Cx36 gene. J. Neurosci. Res. 57:1999;740-752.
2. Bennet M.V.L. Gap junctions as electrical synapses. J. Neurocytol. 26:1997;349-366.
3. Carlen P.L., Skinner F., Zhang L., Naus C., Kushnir M., Perez-Velazquez J. The role of gap junctions in seizures. Brains Res. Rev. 32:2000;235-241.
4. Condorelli D.F., Belluardo N., Trovato-Salinaro A., Mudò G. Expression of Cx36 in mammalian neurons. Brains Res. Rev. 32:2000;72-85.
5. Condorelli D.F., Mudò G., Trovato-Salinaro A., Mirone M.B., Amato G., Belluardo N. Connexin-30 mRNA is up-regulated in astrocytes and expressed in apoptotic neuronal cells of rat brain following kainate-induced seizures. Mol. Cell. Neurosci. 21:2002;94-113.
6. Cross H., Baldeweg T. A possible role for gap junctions in generation of very fast EEG oscillations preceding the onset of, and perhaps initiating, seizures. Epilepsia. 42:2001;153-170.
7. Davidson J.S., Baumgarten I.M. Glycyrrhetinic acid derivatives: a novel class of inhibitors of gap-junctional intercellular communication. Structure-activity relationships. J. Pharmacol. Exp. Ther. 246:1988;1104-1107.
8. Davidson J.S., Baumgarten I.M., Harley E.H. Reversible inhibition of intercellular junctional communication by glycyrrhetinic acid. Biochem. Biophys. Res. Commun. 134:1986;29-36.
9. De Sarro G.B., Croucher M.J., Meldrum B.S. Anticonvulsant actions of DS 103-282: pharmacological studies in rodents and the baboon Papio papio. Neuropharmacology. 23:1984;526-530.
10. De Sarro G.B., De Sarro A., Trimarchi G.R., Nisticò G. Effects of some calcium antagonists upon the activity of common antiepileptic compounds on sound-induced seizures in DBA/2 mice. Gen. Pharmacol. 23:1992;75-82.
11. De Sarro G.B., Nava F., Aguglia U., De Sarro A. Lamotrigine potentiates the antiseizure activity of some anticonvulsants in DBA/2 mice. Neuropharmacology. 35:1996;153-158.
12. De Sarro G.B., Spagnolo C., Gareri P., Gallelli L., De Sarro A. Gabapentin potentiates the antiseizure activity of certain anticonvulsants in DBA/2 mice. Eur. J. Pharmacol. 349:1998;179-185.
13. De Sarro G., Gareri P., Falconi U., De Sarro G. 7-Nitroindazole potentiates the antiseizure activity of some anticonvulsants in DBA/2 mice. Eur. J. Pharmacol. 394:2000;275-288.
14. De Sarro G.B., Gratteri S., Bonacci F., Musumeci S.A., Elia M., De Sarro A. Topiramate potentiates the antiseizure activity of some anticonvulsants in DBA/2 mice. Eur. J. Pharmacol. 388:2000b;163-170.
15. De Sarro G., Donato Di Paola E., Ferreri G., De Sarro A., Fischer W. Influence of some β-adrenoceptor antagonists on the anticonvulsant potency of antiepileptic drugs against audiogenic seizures in DBA/2 mice. Eur. J. Pharmacol. 442:2002;205-213.
16. Dobbins K.R., Saul R.F. Transient visual loss after licorice ingestion. J. Neuro-ophthalmol. 20:2000;38-41.
17. Dodic M., May C.N., Coghlan J.P. Carbenoxolone does not cause a syndrome of mineralcorticoid excess in sheep. Steroids. 63:1998;99-104.
18. Draguhn A., Traub R.D., Schmitz D., Jefferys J.G. Electrical coupling underlies high-frequency oscillations in the hippocampus in vitro. Nature. 394:1998;189-192.
19. Dunham N.W., Miya T.S. A note on a simple apparatus for detecting neurological deficit in rats and mice. J. Am. Pharm. Assoc. 46:1957;208-209.
20. Gareri P., Gravina T., Ferreri G., De Sarro G. Treatment of epilepsy in the elderly. Prog. Neurobiol. 58:1999;389-407.
21. Hosseinzadeh H., Nassiri Asl M. Anticonvulsant, sedative and muscle relaxant effects of carbenoxolone in mice. BMC Pharmacol. 3:2003;3.
22. Jahromi S.S., Wentlandt K., Piran S., Carlen P.L. Anticonvulsant actions of gap junctional blockers in an in vitro seizure model. J. Neurophysiol. 88:2002;1893-1902.
23. Jellinck P.H., Monder C., McEwen B.S., Sakai R.R. Differential inhibition of 11beta-hydroxysteroid dehydrogenase by carbenoxolone in rat brain regions and peripheral tissues. J. Steroid Biochem. Mol. Biol. 46:1993;209-213.
24. Kohling R., Gladwell S.J., Bracci E., Vreugdenhil M., Jefferys J.G. Prolonged epileptiform bursting induced by O-Mg (2+) in rat hippocampal slices depends on gap junctional coupling. Neuroscience. 105:2001;579-587.
25. Li J., Shen H., Naus C.C.G., Zhang L., Carlen P.L. Upregulation of GAP junction connexin 32 with epileptiform activity in the isolated mouse hippocampus. Neuroscience. 105:2001;589-598.
26. Litchfield J.T., Wilcoxon F. A simplified method of evaluating dose-effect experiments. J. Pharmacol. Exp. Ther. 96:1949;99-113.
27. Margineau D.G., Klitgaard H. Can gap-junction blockade preferentially inhibit neuronal hypersynchrony vs. excitability? Neuropharmacology. 41:2001;377-383.
28. McNamara J.O. Cellular and molecular basis of epilepsy. J. Neurosci. 14:1994;3413-3425.
29. Meldrum B.S. Identification and preclinical testing of novel antiepileptic compounds. Epilepsia. 38:1997;S7-S15.
30. Pais I., Hormuzdi S.G., Monyer H., Traub R.D., Wood I.C., Buhl E.H., Whittington M.A., LeBeau F.E. Sharp wave-like activity in the hippocampus in vitro in mice lacking the gap junction protein connexin 36. J. Neurophysiol. 89:2003;2046-2054.
31. Perez-Velazquez J.L., Carlen P.L. Gap junctions, synchrony and seizure. Trends Neurosci. 23:2000;68-74.
32. Rizzo M., Morrone L., Longo P., Sino poli V.A., Spagnolo C., Lo Pilato R., Pelaggi T., David E., Rotiroti D., De Sarro G.B. Simultaneous determination of lamotrigine, felbamate and some conventional antiepileptic drugs using high performance liquid chromathography. Pharmacol. Res. 35:1997;105-109.
33. Rogawski M.A. Mechanism-specific pathways for new antiepileptic drug discovery. French J., Leppik I., Dichter M.A. Antiepileptic Drug Development. 1998;11-27 Lippincott-Raven Publishers, Philadelphia.
34. Ross F.M., Gwyn P., Spanswick D., Davies S.N. Carbenoxolone depresses spontaneous epileptiform activity in the CA1 region of rat hippocampal slices. Neuroscience. 100:2000;789-796.
35. Rouach N., Glowinski J., Giaume C. Activity-dependent neuronal control of gap-junctional communication in astrocytes. J. Cell Biol. 149:2000;1513-1526.
36. Szeute M., Gajda Z., Said Ali K., Hermesz E. Involvement of electrical coupling in the in vivo ictal epileptiform activity induced by 4-aminopyridine in the neocortex. Neuroscience. 115:2002;1067-1078.
37. Tang P.H., Miles M.V., Glauser T.A., DeGrauw T. Automated microanalysis of gabapentin in human serum by HPLC with fluorometric detection. J. Chromatogr., B, Biomed. Sci. Appl. 727:1999;125-129.
38. Traub R.D., Whittington M.A., Buhl E.H., Lebeau F.E., Bibbig A., Boyd S., Cross H., Baldeweg T. Very fast EEG oscillations preceding the onset of, and perhaps initiating seizures. Epilepsia. 42:2001;153-170.
39. Traub R.D., Draguhn A., Whittington M.A., Baldewag T., Bibbig A., Buhl E.H., Schmitz D. Axonal gap junctions between principal neurons: a novel source of network oscillations and perhaps epileptogenesis. Rev. Neurosci. 13:2002;1-30.
40. Venance L., Premont J., Glowinski J., Giaume G. Gap-junctional communication and pharmacological heterogeneity in astrocytes cultured from the rat striatum. J. Physiol. 510:1998;429-440.
41. White H.S. Clinical significance of animal seizure models and mechanisms of action: studies of potential antiepileptic drugs. Epilepsia. 38:1997;S9-S17.
42. White H.S. Comparative anticonvulsant and mechanistic profile of the established and newer antiepileptic drugs. Epilepsia. 40:1999;S2-S10.